Skip to main content

Site notifications

Bristol-Myers Squibb Australia Pty Ltd / AstraZeneca Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

1 result(s) found, displaying 1 to 1
  • Forxiga (dapagliflozin) was approved as an adjunct to diet and exercise in patients with type 2 diabetes mellitus for whom metformin is otherwise indicated but not tolerated. It was also approved as a combination therapy to be used with other drugs to improve glycaemic control.

Help us improve the Therapeutic Goods Administration site